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This paper presents an analysis of an emerging bottleneck in organism engineering, and
paths by which it may be overcome. Recent years have seen the development of a profu-
sion of synthetic biology tools, largely falling into two categories: high-level “design” tools
aimed at mapping from organism specifications to nucleic acid sequences implementing
those specifications, and low-level “build and test” tools aimed at faster, cheaper, and more
reliable fabrication of those sequences and assays of their behavior in engineered biological
organisms. Between the two families, however, there is a major gap: we still largely lack
the predictive models and component characterization data required to effectively deter-
mine which of the many possible candidate sequences considered in the design phase are
the most likely to produce useful results when built and tested. As low-level tools continue
to mature, the bottleneck in biological systems engineering is shifting to be dominated by
design, making this gap a critical barrier to progress. Considering how to address this gap,
we find that widespread adoption of readily available analytic and assay methods is likely
to lead to rapid improvement in available predictive models and component characteriza-
tion models, as evidenced by a number of recent results. Such an enabling development
is, in turn, likely to allow high-level tools to break the design barrier and support rapid
development of transformative biological applications.
Keywords: synthetic biology, organism engineering, design, prediction, automation, metrology, calibrated flow
cytometry
1. INTRODUCTION
The ongoing revolution in synthetic biology is bringing about a
fundamental transformation in our relationship with the world
of living organisms. One of the drivers of this revolution is
the exponential rate of improvement in our ability to sequence,
synthesize, and deliver nucleic acid sequences (Carlson, 2011).
Improvements in reading and writing nucleic acid sequences in
turn enable increasingly rapid modification of an ever-broadening
set of organisms using a growing toolkit of biological mechanisms.
Another key driver is the ongoing adaptation of engineering con-
cepts originating in computer science and electrical engineering
(e.g., Knight and Sussman, 1998; Hasty et al., 2002; Knight, 2003;
Ferber, 2004; Canton et al., 2008). In particular, methods for gen-
erating and exploiting abstraction and modularity have enabled a
“component-based”approach to engineering biological organisms
that greatly simplifies the isolation and dissemination of useful
biological mechanisms.
Viewed through the lens of a “design-build-test” cycle of itera-
tive engineering, the first set of advances addresses build and test,
while the second set addresses design. In both areas, progress is
rapid, and advances are being encapsulated into tools that allow
these improved methods to be widely applied. Between these two
families of tools, however, there is a critical gap of growing impor-
tance: design, as it is currently typically practiced, is simply too
imprecise. As has been widely and uncomfortably observed (e.g.,
Kwok, 2010), the behavior of engineered biological systems is
frequently far different from predictions, typically due to some
combination of unavailable information, inaccurate or incom-
plete models, and insufficiencies in available components. As a
result, current practices for engineering biological systems typ-
ically require many iterations, and both time and cost increase
rapidly with the complexity of the system to be engineered.
A number of recent results, however, indicate that these prob-
lems are becoming tractable to address. The goal of this manuscript
is thus to analyze the problem landscape from a systems engineer-
ing perspective, producing a roadmap for breaking the biological
design barrier and enabling the rapid and effective engineering
of complex biological systems. Section 2 begins by analyzing the
design-build-test cycle of biological engineering, developing an
information-based metric for analyzing both the complexity of
biological engineering problems and the efficacy of various engi-
neering methodologies. Section 3 then applies this metric to ana-
lyze the relative potential impact from three complementary lines
of tool development: high-throughput assays, improved device
families, and predictive modeling and design. Narrowing the focus
to predictive modeling, Section 4 examines the requirements nec-
essary for an assay to effectively support predictive modeling, and
illustrates how these can be satisfied through the example of a
recently developed method for calibrated flow cytometry. Section
5 then connects assay capabilities back to the engineering of bio-
logical organisms by showing how calibrated flow cytometry has
been used for intra-sample validation, to develop high-precision
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Beal Breaking the biological design barrier
predictive models, and to support development of improved
repressor devices. Finally, Section 6 summarizes and presents a
roadmap for extending these capabilities to be readily applicable
to a broad class of systems and organisms.
2. QUANTIFYING BOTTLENECKS IN ENGINEERING
BIOLOGICAL ORGANISMS
Engineering is often conceived of as an iterative “design-build-
test” process (Figure 1A). Although more mature engineering
disciplines typically develop more sophisticated workflows [e.g.,
continuous integration (Duvall, 2007) and Agile processes (Lar-
man, 2004) in software design, design for test (Crouch, 1999)
in electronics, waterfall processes (INCOSE, 2010) for complex
electromechanical systems], the classic iterative model is a good
starting point for analyzing current synthetic biology approaches
to the engineering of biological systems. Taking this approach, we
can apply Amdahl’s law (explained in Section 1) to quantify process
bottlenecks in the engineering of biological organisms. Here, the
true cost of design becomes clear when it is considered as a
multi-iteration search process, and can be estimated using the ratio
of information required for a design to the information gained per
test. This analysis can then be applied to assess the current ecosys-
tem of design tools, identifying critical gaps and opportunities.
For the convenience of the reader, Figure 2 provides a table of
notation used in this section.
2.1. QUANTIFYING BOTTLENECKS: AMDAHL’S LAW
In computer science, Amdahl’s law (Amdahl, 1967) is frequently
used for analyzing cost–benefit tradeoffs in optimizing the speed
of complex processes. In essence, Amdahl’s law is simple arith-
metic: if a particular stage of a sequential process takes time Tstage
to complete, and the remainder takes a total time Ttotal−Tstage,
then optimizing that stage to be k times faster gives an overall
speedup of:
ktotal = Ttotal(
Ttotal − Tstage
)+ Tstagek (1)
FIGURE 1 | When analyzing synthetic biology against a classic
design-build-test cycle (A), analysis of a single cycle hides the cost of design,
since the relative effort expended in a single cycle is typically quite low:
(B) illustrates this with typical examples of time expended in a single cycle: a
few minutes or hours of design, followed by construction of a design via
BioBrick assembly (Knight, 2003) from existing sequence fragments or via an
expedited order from a next-generation synthesis company, and then a 1-day
test (e.g., a simple bacterial circuit) or a 1-week test (e.g., testing a memory
circuit). A better measure, however, also takes into account the number of
cycles required due to imprecision in design: (C) illustrates a sequence of
design-build-test cycles in which any cycle that turns out not to be productive
is accounted as a cost of problems in design.
FIGURE 2 |Table of significant notation used for analysis of organism engineering bottlenecks.
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Beal Breaking the biological design barrier
In other words, the efficacy of improving one stage in a process
(e.g., by increasing parallel throughput) is bounded by the fraction
of time spent in the other stages.
For example, if there are two stages, the first taking 2 days and
the second taking 1 day, then a k= 2 speedup of the first stage, to
1 day, will improve the total speed by 3/1+ 1= 1.5 times, while a
k= 2 speedup of the second stage to half a day will only improve
the total speed by 3/2+ 0.5= 1.2 times.
Let us consider how this analysis applies to the design-build-test
cycle (Figure 1A) for one of the most common process workflows
in the practice of synthetic biology:
• Design proposes a set of nucleotide sequences that will be assayed
with the aim of advancing toward some engineering goal.
• Build physically realizes the desired nucleotide sequences
through some combination of protocols such as for synthesis,
assembly, editing, and purification.
• Test assays the results of gene expression from these nucleotide
sequences under various experimental conditions.
This general schema covers much of the practice of synthetic
biology, from developing sensors to tuning chemical synthesis,
from directed evolution to circuit engineering, from microbes to
specialty mice.
A simplistic analysis could simply consider the time required
for each of these stages in a cycle:
Tcycle = Tdesign + Tbuild + Ttest (2)
Applying Amdahl’s law to this formula, we can determine where
there is the most opportunity for improvement in a given engi-
neering cycle. At present, this is typically dominated by building
or testing, which frequently require days to weeks, depending on
the particular constructs and organisms involved, as illustrated in
Figure 1B. From the single-cycle perspective, then, design would
appear to be only a niche concern, relevant only for subareas with
particularly high computational requirements, such as rational
design of proteins.
Since there may be many cycles, however, a better approxima-
tion of the time required for engineering a biological organism to
meet some particular specification S is:
Ttotal (S) = ncycles (S)× Tcycle (3)
The number of cycles, in turn, is affected by the quality of
choices made during each design phase. For example, design
choices that lead to dead ends or simply turn out to fail may
result in unproductive cycles that may reasonably have their costs
assigned to design, as illustrated in Figure 1C.
Since every engineering project is likely to face different chal-
lenges, how can we analyze the effect of design methods on the
number of cycles? At a fine grain, of course, we cannot predict
which cycles will be unproductive – otherwise, they would not
happen in the first place. We can, however, quantify the efficacy of
any engineering method by viewing the sequence of design-built-
test cycles as an incremental search through the space of possible
designs. Viewed in this way, the expected performance of an engi-
neering method can be analyzed using various well-established
methods (Russell and Norvig, 2003) from artificial intelligence
and information theory.
2.2. INFORMATION-BASED ESTIMATION OF ENGINEERING CYCLES
Let us consider the engineering process as a search through the
space of possible designs. This design space C consists of the set
of all possible system configurations within the scope of consid-
eration. For any given design specification S, the subset GS⊆C is
the set of “goal” configurations that sufficiently satisfy the specifi-
cation (we will assume that these are simple to recognize when
tested). The search process is thus an attempt to either iden-
tify at least one member of GS or to determine that the set is
empty.
For example, consider engineering of a metabolic pathway that
expresses five enzymes: if each enzyme’s expression is driven by
a constitutive promoter and 5′UTR chosen from rationally engi-
neered libraries of 10 of each type (e.g., via Salis et al., 2009), and
these functional units are joined to form a single plasmid, then
there are 105× 105× 5!× 25= 3.8× 1013 possible configurations
(105 for five independent choices from a set of 10 promoters,
times 105 for five choices from 10 5′UTRs, times five-factorial
possible orderings, times 25 for five independent choices of plus
or minus strand). For another example, consider engineering as
a circuit of 7 repressors drawn from the orthogonal library of
20 in Stanton et al. (2014). Selecting the repressors and organiz-
ing their functional units on a plasmid gives
(
20
7
)
× 7! × 27 =
5.0×1010 possible configurations [there are
(
20
7
)
possible combi-
nations of library repressors, times seven-factorial possible order-
ings, times 27 for seven independent choices of plus or minus
strand].
Prior knowledge about the likelihood of configurations being in
GS can be modeled by a normalized weight function w0: C→[0, 1],
such that configurations known not to be in GS map to 0 and those
most likely to be in GS map to 1. After each cycle, this function is
updated to a new wi based on the information learned from that
cycle’s tests. Any cyclic engineering process may then be modeled
by the following meta-algorithm:
1. Select a set of candidate configurations c⊆C, on the basis of wi.
2. Build and test all members of c.
3. If some c∈GS, then SUCCEED.
4. Incorporate knowledge gained from the tests to generate wi+1.
5. If wi+1 is uniformly zero, then FAIL, since GS has been
demonstrated to be empty. Otherwise, return to step 1.
Using information theory, we can quantify how hard it is to
find goal configurations by considering the selection of candidates
at random1. By the standard definition of entropy, the number of
1The assumption of random exploration may at first seem strange to those unfa-
miliar with information theory, since any engineering effort is of course guided
by knowledge, experience, and educated guesses. In this information-based for-
mulation of the engineering problems, however, all such guidance is encoded by
the weight function. Whatever, choice remains is arbitrary and cannot in general
outperform random choice.
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Beal Breaking the biological design barrier
bits H (S, i) for the ith cycle of design toward some specification S
is thus:
H (S, i) = log2

∑
c∈C
wi (c)∑
c∈GS
wi (c)
 (4)
where wi(c) is the estimated likelihood of configuration c belong-
ing to GS given the information available at cycle i. This is thus an
information-based measure of the progress of engineering a system
over time.
Note that better information about the likelihoods of configu-
rations belonging to c reduces the number of bits, until in the limit
wi puts a non-zero weight only on members of GS. At this point,
the number of bits is zero and success is certain. Complementarily,
lack of information and sparse goals increase the number of bits
toward an upper limit of log2|C |. Thus, the metabolic pathway
example above is an engineering problem of up to 45.1 bits and
the circuit example up to 35.5 bits.
The efficacy of an engineering method may then be evaluated
in terms of the number of bits of information obtained per cycle,
formally:
∆Hi = H (S, i)−H (S, i + 1) (5)
In general, the number of bits remaining should decrease with
each additional assay, giving a positive ∆Hi, and the greater the
decrease in entropy, the better the efficacy of the method.
To illustrate these notions of information gain, consider the
metabolic pathway example, beginning with no information about
the appropriate expression levels. Some examples of information
gain:
• Determining that enzyme #2’s 5′UTR should be in the upper
half of the expression range gains 1 bit of information.
• Determining which promoter should be used for enzyme #2
gains 3.32 bits of information.
• Determining that enzymes #3 and #4 should be expressed
with matching promoter/5′UTR combinations gains 6.64 bits
of information.
• Using insulators that eliminate the effect of ordering and strand
choice gain 11.91 bits of information.
• High-throughput screening of 1010 arbitrarily chosen combina-
tions gains only 0.0004 bits of information.
Notice that in these examples, the model-driven information
gains are much greater than the gains from brute-force screen-
ing – even with a rather large throughput. The relative balance
of model-driven and exploration-driven approaches depends on
the scale of the problems. For example, if the pathway contained
only three enzymes rather than five, it would only be a 25.5-bit
configuration space and could be screened completely using less
than 108 combinations. Notice also, that some of these infor-
mation gains are “one shot” while others are not. For example,
using insulators is a single choice, and cannot narrow the design
space further. A method that can incrementally refine expression
level choices, however, might be applied iteratively to complete the
entire design, providing a consistent expected information gain
E[∆H ] per cycle.
A conservative estimate of the expected number of cycles
nˆcycles(S) required to engineer specification S by a particular engi-
neering method with an expected information gain of E[∆H ] per
cycle may thus be computed by assuming there is only a single pos-
sible solution in GS. Under this assumption, the estimated number
of cycles is:
nˆcycles (S) = H (S, 0)
E [∆H ]
(6)
Returning to the original equation, we may thus estimate the
expected time to be required to engineer a biological system to
satisfy a given specification S as:
Tˆtotal (S) = H (S, 0)
E [∆H ]
× Tcycle (7)
3. POTENTIAL IMPACT OF IMPROVED ENGINEERING TOOLS
Let us now bring this analysis back to the original question: what
are the bottlenecks in engineering biological organisms, and the
key points for investigation to improve the situation? Having cast
the problem of engineering biological organisms in information-
based terms, we can see that there are only three terms in the
equation for the estimated time for engineering. Each term then
implies a particular strategy for improving speed:
1. decreasing the amortized time per configuration assay by
decreasing amortized Tcycle (e.g., by decreasing the time per
cycle or by running more cycles in parallel),
2. decreasing the effective bits H (S, 0) required by vastly enriching
the number of acceptable “goal” configurations, and,
3. increasing the number of bits E[∆H ] of design-constraining
information expected to be gained per configuration assay.
The first strategy focuses on the“low-level”tools aimed primar-
ily at the build and test aspects of the engineering cycle. Capabilities
in this area are increasing rapidly, but there are sharp limits in
what can be enabled by this strategy alone. The second and third
strategies relate more to “high-level” design tools for mapping
from a specification to a candidate configuration in C. Here, there
is a critical gap stemming from the difficulty of predicting the
behavior of a configuration, which we analyze along with emerging
opportunities for bridging this gap.
3.1. DECREASING TIME PER ASSAY: HIGH-THROUGHPUT SCREENING
The time required for a cycle of testing is strongly limited by the
underlying physical processes involved in build and test. Even if
fabrication time might be greatly reduced, the time for an in vivo
assay is an immutable bottleneck set by the inherent dynamics
of the organism being assayed. This can potentially be mitigated
through in vitro assays, assuming that there are models and design
tools that can mitigate the effect of differences between in vitro
and in vivo environments. However, even the fastest in vitro assays
(e.g., Carlson et al., 2012; Sun et al., 2013), which operate on a time
scale of only hours, are physically limited by the dynamics of the
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Beal Breaking the biological design barrier
systems to be assayed. Thus, serial improvements to throughput
are likely limited to around one order of magnitude increase in
throughput relative to typical cell culture assays.
For the complementary approach, decreasing the amortized
time per configuration assay through massive parallelization of
high-throughput screening, typical practice is much farther from
physical limits, giving the opportunity for much more improve-
ment in throughput. High-throughput parallel screening is already
a subject of much investigation, a recent review of which may be
found in Dietrich et al. (2010). Significant research and commer-
cial development is being invested in multiple tools designed to
increase both capabilities and accessibility, including in robotics
(e.g., Vasilev et al., 2011; Hillson et al., 2012; Linshiz et al., 2012),
microfluidics (e.g., Kong et al., 2007; Gulati et al., 2009), evolu-
tionary methods (e.g., Esvelt et al., 2011; Cobb et al., 2012; Lynch
and Gill, 2012), and languages for low-level specification and data
exchange (e.g.,Bilitchenko et al., 2011; Galdzicki et al., 2012; Myers,
2013). This portion of the tool ecosystem is thus quite healthy and
rapidly evolving.
Increasing throughput, however, has sharp limits in efficacy,
because the configuration space grows exponentially with the
number of bits, which in turn typically scales linearly with the
complexity of the system being engineered. As a result, “brute
force” approaches through high-throughput screening can readily
solve problems up to a certain number of bits, but are effectively
useless when addressing problems only a little bit larger. Figure 3A
illustrates this scaling problem by comparing the circuit and meta-
bolic pathway examples from the previous section with the size of
configuration space that can be explored with a 1-week build/test
cycle at various rates of high-throughput screening. When samples
are prepared manually, the rates that can be effectively sustained for
a single laboratory worker are on the order of 102 configurations
per cycle (e.g., a few replicates in 96-well plates). A well-pipelined
fluid-handling robotics cell can prepare such assays continuously,
raising the rate to around 104 configurations per cycle. Other tech-
niques can potentially raise the rate by orders of magnitude, but
there are limits due to various pragmatic barriers: Dietrich et al.
(2010) calculated effective parallelism limits of high-throughput
screening to be around 106–109 configurations per screening assay.
As can be seen, even at high rates of throughput, only moder-
ately complex configuration spaces can be explored in a reasonable
period of time.
High-throughput screening is still a valuable component of the
toolkit for engineering biological organisms. As the capacity and
accessibility of high-throughput screening continue to increase,
brute-force screening is likely to be sufficient for realizing a large
number of “low hanging fruit” applications, particularly certain
classes of medical, sensor, and chemical synthesis applications
where the engineered organism only needs to operate for a rel-
atively short period of time in a tightly controlled and isolated
environment.
When contemplating longer lived systems in less controlled
environments, however, it is reasonable to expect that there will
generally be a need for more complex mechanisms that can ensure
safety, stability, and effective operation under a range of con-
ditions. Evolutionary methods are often proposed as a means
of obtaining continuous incremental improvement toward such
more complex systems (e.g., Cobb et al., 2012; Lynch and Gill,
2012). Great progress has been made with these methods, and they
have proven highly effective for solving problems with simple spec-
ifications in permissive spaces (e.g., Chudakov et al., 2010; Brustad
and Arnold, 2011). Computer science researchers, however, have
identified a key set of open problems that must be addressed in
order for evolutionary methods to be effective for complex engi-
neered systems of any sort, biological, or otherwise (Forrest and
Mitchell, 1993; O’Neill et al., 2010). It is not yet clear whether it
FIGURE 3 | Decreased time per assay has sharply limited benefits, as
illustrated by comparison of the bit size of example moderate-
complexity circuits to rates of configuration space exploration
(A). Solid lines show the number of bits of configuration space that can
be assayed in a sequence of 1-week cycles with various methods
(starting with a single parallel assay at week 1), while dashed lines show
the complexity of the example circuits in Section 2. Improving models
and components can dramatically reduce the required number of assays:
(B) illustrates how a model-driven design process for the
seven-repressor circuit might progress incrementally by breaking the
system into three sequentially engineered subsystems (solid lines with
diamonds marking sequence steps; manual is blue, robotic is green), and
how that might be further improved with insulators that eliminate the
effect of ordering and strand choice (dashed lines with stars marking
sequence steps; manual is blue, robotic is green). For (B), progress
toward completion is shown by graphing H (S, 0)−H (S, i ) for each circuit.
Note that for the lowest manual line, no diamond appears because the
first step is not completed for more than 6 months.
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Beal Breaking the biological design barrier
is even possible to solve these problems for synthetic biology, and
unless they can be solved, effective engineering of even moder-
ately complicated synthetic biology systems will necessarily require
methods that include a more model-driven approach to design.
3.2. DECREASING REQUIRED ASSAYS: IMPROVING COMPONENTS
AND MODELS
The other half of Equation (7), estimating number of cycles,
addresses how large the effective configuration space is and how
effectively an engineer can apply assays in searching for a goal con-
figuration. Here, there is a major and well-recognized gap in the
current tool ecosystem: given the current set of available parts and
models, it has not generally been possible to accurately predict the
behavior of multi-element designs except in certain special cases
(Kwok, 2010; Lux et al., 2012).
At higher levels of abstraction, mapping from behavior speci-
fications for cell aggregates or individual cells to specifications of
candidate regulatory networks intended to implement those spec-
ifications, there are a number of candidate tools and approaches.
These encompass a wide variety of models, addressing computa-
tion and control, metabolic synthesis, and even the development
of structure and patterns (e.g., Pharkya et al., 2004; Beal and
Bachrach, 2008; Pedersen and Phillips, 2009; Moriya et al., 2010;
Beal et al., 2011; Marchisio and Stelling, 2011; Yousofshahi et al.,
2011; Huynh et al., 2013). Despite some notable current gaps2,
this portion of the design space appears to be generally susceptible
to a variety of methods from computer science, electronic design
automation, and signal processing.
Because of the difficulty in predicting the behavior of multi-
element designs, however, no high-level design tool is currently
capable of supporting an effective search of a large configuration
space. Instead, at present, these tools generally either stop at the
design of an “abstract” circuit that can be realized into many dif-
ferent configurations (e.g., Beal et al., 2011), require collections
of devices, and/or data about devices that are not currently avail-
able (e.g., Pedersen and Phillips, 2009; Rodrigo et al., 2011; Yaman
et al., 2012; Huynh et al., 2013), or can generate large numbers
of candidate configurations with no reliable means of distinguish-
ing, which (if any) are likely to actually meet the specification (e.g.,
Czar et al., 2009; Bilitchenko et al., 2011). In all cases, however, the
fundamental problem is a lack of precision in the available mod-
els for crossing the gap between a sequence specification and a
prediction of the expression that will result from this sequence in
context.
There are two basic approaches to addressing this problem,
corresponding to the numerator and denominator of the esti-
mated number of cycles. The first approach is to decrease the
effective complexity of the configuration space H (S, 0) by some
combination of:
1. increasing the signal-to-noise characteristics of intended com-
ponent interactions, and
2. decreasing the effect of unintended interactions between
components and their environment.
2For example, most tools for designing computational circuits have focused on
digital logic, rather than analog or hybrid systems.
Improvements of either type decrease the degree of coupling
between choices in a configuration, i.e., the likelihood of incom-
patibility between choices: the lower the likelihood of two inde-
pendent design choices being contained within GS, the higher the
degree of coupling between choices, because any given design
choice must more carefully take into account the other choices
that have been made. Coupling and effective complexity have a
well-established relationship in both complexity theory (Kanefsky
and Taylor, 1991; Hogg et al., 1996) and statistical physics (Krza-
kala and Kurchan, 2007; Dall’Asta et al., 2008; Zdeborová, 2008):
as degree of coupling decreases, the structure of the configuration
space undergoes a dramatic phase transition, such that it becomes
easy to either find a goal configuration or determine that none
exists. Put more intuitively: it is much easier to engineer with
components that are less delicate.
In synthetic biology, a number of different ongoing efforts are
aimed at improving signal-to-noise and at decreasing unintended
interactions. Methods for improving signal-to-noise are currently
largely focused on improving the number of available orthog-
onal high-amplification regulatory mechanisms. A number of
approaches are being pursued, including recombinases (e.g., Bon-
net et al., 2013), homolog mining (e.g., Stanton et al., 2014), and
high-performance synthetic repressors (e.g., Kiani et al., 2014). At
the same time, methods for decreasing unintended interactions are
being investigated across a large range of targets, from decreasing
promoter/5′UTR interaction (e.g., Lou et al., 2012; Mutalik et al.,
2013), to making interactions between functional units more pre-
dictable by cotransfection (Beal et al., 2012, 2014), to construction
of entirely orthogonal systems of transcriptional machinery (Neu-
mann et al., 2010; Schmidt, 2010). It is unclear at present, however,
how quickly these efforts can progress, how well their goals can be
achieved, and in which classes of organisms.
The complementary approach to reducing H (S, 0) is increasing
E[∆H ], so that the search for functional configurations can be bet-
ter guided by improved models of components and their intended
and unintended interactions. More precise predictive models can
improve the rate of information gain in a number of ways, notably
including:
• Entire subspaces of non-functional configurations can be elim-
inated from consideration without any assay.
• An assay of one configuration can provide information (adjust-
ments to wi) about a large family of related configurations.
• Complicated systems can be decomposed hierarchically or
thematically into subsystems whose details can be designed
independently.
Figure 3B illustrates an example of how a model-driven engi-
neering process might exploit such techniques, using the example
of a seven-repressor circuit from Section 2. For this example, let
us assume the same assay rates as for the high-throughput screen-
ing comparison in Figure 3A, but instead of a brute-force search
of the space, the circuit is broken into three modular subsystems
and each of these engineered sequentially. First, all possible imple-
mentations of a subsystem of three repressors are assayed, followed
in turn by two more two-repressor subsystems, covering the cir-
cuit. Note that the information gain for each stage is not uniform,
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because of how the combinatorics of possible remaining options
differs. The repressors are then assayed for signal levels and orthog-
onality, and this information used to pick the best three compatible
candidates for each subsystem: all combinations of these candi-
dates are constructed, and the best version accepted, assuming
that it is sufficiently functional. Such a process may not iden-
tify the optimal system, but instead makes incremental progress
toward identifying a “good enough” system, as long as the mod-
els are predictive enough and component coupling low enough to
enable the subsystem assays to effectively constrain the candidates
for the final design. The example design would still be too com-
plex to search effectively with manual assays (an expected time of
nearly 5 years at the specified rate), but can be readily tackled with
fluid-handling robotics. Additional improvements to the design
space might further improve the effective bits per assay: for exam-
ple, with insulators that eliminate the effect of ordering and strand
choice, even manual assay preparation is a viable strategy.
Construction of predictive models to enable such modular
approaches to engineering has been a major goal of synthetic biol-
ogy since its inception (e.g., Knight and Sussman, 1998; Elowitz
and Leibler, 2000; Gardner et al., 2000; Weiss, 2001). Significant
progress has been made in predictive engineering of behaviors of
individual circuit components (e.g., Salis et al., 2009; Liu et al.,
2012; Lou et al., 2012; Borujeni et al., 2013; Kosuri et al., 2013).
Successful prediction results for the interaction of multiple com-
ponents, however, have been rare and generally applicable only to
special cases (e.g., Rosenfeld et al., 2007; Stricker et al., 2008; Ellis
et al., 2009; Tabor et al., 2009).
In the next section, we will argue that a major barrier to
progress in predictive modeling has been the unavailability of
sufficient assay methods. Recent improvements in assay meth-
ods, however, have enabled previously unattainable precision in
quantification. Improved precision then enables better predictive
models, supporting new and more effective approaches to both
the engineering of multi-component circuits (Beal et al., 2014;
Davidsohn et al., 2014) and to the engineering of individual com-
ponents (Kiani et al., 2014). All of this amounts to a significant
increase in the amount of information that can be gained per
assay, entirely complementary to high-throughput screening and
component improvement, and offers the opportunity for rapid
advancement in the speed of biological organism engineering.
4. MEASUREMENT ASSAYS TO SUPPORT MODEL-DRIVEN
ENGINEERING
Let us now focus on the foundation for model-driven engineering:
sufficiently powerful measurement assays. Effective quantitative
modeling is impossible without being able to obtain accurate
and precise measurements of the phenomena to be modeled.
This section thus first analyzes what is required for an assay
aimed to support model-driven engineering, then presents in
detail an example of a recently developed method, calibrated flow
cytometry, that satisfies these requirements.
4.1. ASSAY REQUIREMENTS FOR EFFECTIVE MODELING
Any effective synthetic biology program of quantitative model-
ing requires assays with the following capability: absolute unit
measurements from large numbers of single cells. To see why, let
us break this statement up and consider it one point at a time.
4.1.1. Absolute unit measurements
Much of the prior work in both systems and synthetic biology
reports results in relative or arbitrary units – in other words,
values that are not tied to any SI unit. This is an unusual prac-
tice for a scientific field, but so widespread that it goes virtually
unremarked upon. When relative units are used, the focus of scien-
tific reproducibility is not the individual measurements, but their
relationship, e.g., the fold-repression exhibited by a transcription
factor.
Relative units, however, cannot be combined across different
experiments. This means that models of individual components
or interaction phenomena cannot in general be combined to pre-
dict the behavior of new configurations. For quantitative models
to be portable across experiments, systems, and laboratories, they
must therefore be based on measurements tied to some absolute
standard, preferably in SI units3.
4.1.2. Single cells
In many synthetic biology systems, there is significant variation
in the behavior of individual cells. Many assays, however, obtain
only a cumulative or mean measurement across an entire pop-
ulation of cells. As a result, such population-level assays cannot
distinguish between radically different distributions of values. For
example, Figure 4 illustrates three very different distributions of
fluorescence: a tight homogeneous distribution, a highly variable
unimodal distribution, and a strongly bimodal distribution, all of
which have the same mean and total fluorescence over the pop-
ulation. Since high cell-to-cell variation is so common, and has
been shown to be important in understanding many systems (e.g.,
Rosenfeld et al., 2005; Beal et al., 2014), effective quantitative mod-
eling requires assays that can obtain their absolute measurements
from individual cells.
4.1.3. Large numbers of cells
Finally, not only is it important to take measurements of individ-
ual cells, but to obtain them from large numbers of individual
3The RFU method (Kelly et al., 2009) attempts to avoid this necessity by comparing
with a standard constitutive promoter; the behavior of that promoter, however, may
change radically from context to context.
FIGURE 4 | Assays that measure population means or totals cannot
distinguish between even radically different distributions of
expression. For example, the tight (A), broad (B), and bimodal
(C) distributions illustrated above all have the same mean and total
fluorescence.
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cells. The reason is that there are often multiple different phe-
nomena driving different modes of variation in the behavior of a
population of cells. Some of the key classes of phenomena driving
variation include:
• Inherent process stochasticity: e.g., transcription, translation,
replication.
• Cell-to-cell differences: e.g., size, cycle state, health, mutations,
location.
• Protocol stochasticity: e.g., transfection variation, insertion site.
• Protocol execution issues: e.g., reagent variation, contamination,
instrument drift.
In modeling and engineering a system, each of these classes
must be handled differently. For example, inherent stochasticity
has largely uncorrelated effects on individual genetic components,
while cell-to-cell differences have highly correlated effects on all
of the components within an individual cell. Likewise, protocol
stochasticity can often produce distributions of individual cell
behaviors predictably controlled by variables in the protocol, while
protocol execution issues are more generally unpredictable and
must be detected and appropriately compensated for.
It is for this reason that large numbers of individual cell mea-
surements are needed, in order to be able to accurately distinguish
and resolve multiple modes of variation. Figure 5 shows illustra-
tive examples of complex distributions of cell behaviors, labeled to
indicate aspects of the distribution that can be used to quantify var-
ious significant mechanisms for understanding system behavior.
For example, Figure 5A, from Adler et al. (2014) shows tran-
sient transfection of a plasmid constitutively expressing red mKate
fluorescent protein into HEK293 mammalian cells. Fluorescence
is measured on two channels of a flow cytometer, one config-
ured to measure mKate, the other to measure the yellow EFYP
fluorescent protein. The distribution is strongly bimodal, with
non-transfected cells expressing little red and transfected cells
strongly expressing red: the relative number of non-transfected
cells is proportional to transfection efficiency, while the range of
expression in the transfected population indicates the range of
variation in dose and resources from cell to cell. At the same time,
the second channel can be used to quantify both autofluorescence
(from the non-transfected cells) and the degree of spectral overlap
between yellow and red channels of the instrument in its current
state (from the location of the inflection point in the transfected
population). Similar mechanisms are at work in Figure 5B, taken
from the data of Beal et al. (2014), showing a cotransfection of two
Sindbis RNA replicons into BHK-21 mammalian cells, one con-
stitutively expressing mKate, the other EBFP2. The relative size of
the lower-left population of cells expressing minimal fluorescence
is proportional to the transfection efficiency, and cell-to-cell varia-
tion in resources is proportional to the variance along the diagonal
axis. In addition, the number of cells and variance of the off-axis
component of the distribution indicate the size and distribution of
the initial dose, since all doses are quantized (i.e., it is not possible
to transfect a fractional replicon) and smaller initial doses have
higher variance.
The exact number of observations required to quantify mech-
anism models from distributions such as these depends on the
structure of the distributions involved. In general, however, more
samples are required to obtain the same level of accuracy for more
complex distributions or distributions with less clearly separated
components. To give a sense of scale, the experiments reviewed in
this section and the next range from around 30,000 to 1,000,000
samples per condition assayed, depending on the particular goals
and requirements of the assay.
From these arguments and examples, we can see that an assay
that can obtain absolute measurements from a large number of
FIGURE 5 | Examples of flow cytometry data showing complex
population variation driven by multiple phenomena, with labels on key
portions of the distribution used for estimating model parameters: (A)
transient transfection of a single constitutively expressed fluorescent
protein, from Adler et al. (2014), and (B) cotransfection of two
replicons with constitutively expressed fluorescent proteins, from
Beal et al. (2014). Both graphs indicate distribution density with color,
with dark red indicating the maximum density, and outlier data (those
in areas with less than 5% of maximum density) indicated by gray
dots.
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Beal Breaking the biological design barrier
single cells has the potential to provide a great deal of insight into
the behavior of a biological system. Moreover, it is likely to be dif-
ficult to make accurate predictive models of cell behavior without
being able to use such a capability to separate and quantify the
different modes of variation affecting cell behavior.
4.2. CALIBRATED FLOW CYTOMETRY
Until recently, there has been no readily accessible assay for gene
expression that could satisfy the requirement for absolute mea-
surements of large numbers (on the order of 105) of single
cells. This has changed, however, with the development of the
TASBE method for calibrated flow cytometry (Beal et al., 2012),
which builds on pre-existing calibration methods to enable high-
throughput measurement of equivalent absolute units from mul-
tiple fluorescent species (often proteins, though other classes of
molecule can also be used).
As an instrument, flow cytometers already fulfill two of the
three assay requirements, since they break a sample into individ-
ual particles (many corresponding to individual cells) and take
fluorescence measurements on multiple channels simultaneously
from large numbers of those particles. Better yet, flow cytome-
ters have become widely available, and many flow cytometers have
high-throughput screening capabilities that make it easy to eval-
uate many samples in a short time. The measurements produced,
however, are in arbitrary units, which can vary wildly depending
on the machine and its settings and which are subject to drift over
time. Thus, in order to transform flow cytometry into an assay
capable of supporting modeling, it is necessary to add calibra-
tion controls that can enable a reliable mapping from relative to
absolute units.
The TASBE method (Beal et al., 2012) builds on prior methods
for flow cytometry calibration (Roederer, 2001, 2002; Schwartz
et al., 2004; Hoffman et al., 2012), enhancing them to allow
equivalent units to be read from all channels of a flow cytome-
ter. The TASBE method is modular and can be incorporated as
an extension to nearly any other flow cytometry protocol. Cells
should be prepared and gated to remove non-cell particles as dic-
tated by the base protocol; the TASBE method just requires that
each experiment also include measurements from a set of cali-
bration controls (some of which should already be part of any
experiment).
In particular, the method uses a set of four controls to compute
a calibrated “color model” for converting data from arbitrary units
to absolute units, as illustrated in Figure 6:
1. a negative control, to quantify autofluorescence;
2. single-positive controls for each fluorescent species, to quantify
spectral overlap;
3. fluorescent beads calibrated to an absolute standard of Mole-
cules of Equivalent Fluorescein (MEFL), such as SpheroTech
RCP-30-5A beads (SpheroTech, 2001);
4. for each fluorescent species not measured in the FITC chan-
nel, a multi-color control with equivalent co-expression of that
species and the species measured in the FITC channel.
The first two controls are used to remove fluorescence conta-
mination from the measurements; the latter two controls are used
to convert to absolute units.
4.2.1. Compensation for fluorescence contamination
Fluorescence measurements are contaminated in two ways. First,
cells (and the medium in which they are suspended) have some
degree of autofluorescence, adding a consistent background to any
fluorescence measurement. Second, there is often overlap in the
excitation and emission spectra of fluorescent species, such that
the measurements for each species will include “spectral bleed”
proportional to each other species’ concentration and degree of
overlap. The amount of overlap depends on particular fluorescent
species and the configuration and settings of the flow cytometer.
Mean autofluorescence on each channel can be estimated
from a negative control, either wild-type or a null transfec-
tion/transformation (null is preferred over wild-type, because
some cells’ fluorescence properties change in response to the
stress of transfection/transformation protocols). Autofluorescence
is typically normally distributed; Figure 7A shows a typical exam-
ple of low autofluorescence (from untransfected HEK293 cells),
computing both the mean (solid red line) and two standard
deviations (dotted red lines).
Once autofluorescence has been quantified, spectral overlap
can be estimated from strong constitutive expression of each fluo-
rescent protein individually. With a single protein being expressed,
any fluorescence observed significantly above autofluorescence in
any other channel must be the result of spectral bleed. This is a
linear effect, and thus may be estimated from the mean ratio of the
two measurements for highly expressing particles after autofluo-
rescence is removed. Figure 7B shows an example of computing
the spectral bleed from strong constitutive expression of the red
fluorescent protein mKate into the FITC channel (in this case
intended to be used for quantifying EFYP expression), finding
an approximate bleed of around 0.1%. Note that this is a rela-
tive measure, depending on the settings of both channels involved,
rather than an absolute measure of the percentage of energy con-
taminating. This distinction is important because the purpose is
to be able to use the (relative) measurement on one channel to
correct the (relative) measurement on the other.
Once autofluorescence and spectral bleed have been quantified,
they may be removed using an affine transform, as described in
Roederer (2001, 2002). High spectral bleed, however, still results
in increased noise, as described in Roederer (2002). For high-
precision quantification, a best-practices standard for spectral
bleed is thus <1%, though higher levels can be tolerated for some
purposes. The writeup in Beal et al. (2012) also describes a method
for selecting species/channel combinations with minimal overlap.
With presently available instrumentation and fluorescent species,
it is typically possible to meet this best-practices standard for two
to four species, depending on the instrument and its configuration.
Finally, note that while some flow cytometers have features to
perform their own spectral compensation, it is generally better to
take data uncompensated and apply compensation later. Built-in
compensation is proprietary software that cannot be validated,
and so it is difficult to tell whether compensation is performed
correctly; moreover, in those cases where it goes wrong, it is not
possible to re-compensate correctly without the original data.
Similarly, at present most commercial flow cytometry software
does not compensate for autofluorescence, so such compensation
mechanisms should not be used in the presence of non-trivial
autofluorescence.
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FIGURE 6 | The TASBE method (Beal et al., 2012) for calibrated flow
cytometry uses four controls: correction for autofluorescence and
spectral overlap is computed from the negative and single-positive
controls. Calibration beads provide a conversion from arbitrary units to
molecules of equivalent fluorescein (MEFL) on the FITC channel, and
multi-color controls allow all other channels to be converted to equivalent
FITC units and thence to MEFL. Data shown are from sample material
on Adler et al. (2014).
4.2.2. Conversion to absolute units
The measurements returned by a flow cytometer are highly relative
and subject to change: not only do they depend on the machine, its
configuration, and the laser and detector settings for a particular
assay, but also the instruments tend to drift in calibration over time
as well. Various standard fluorescent beads have been developed to
deal with this calibration problem, and have been demonstrated to
provide standardizable precise measurements across a wide range
of instruments and channels (Schwartz et al., 2004; Vogt et al.,
2008; Wang et al., 2008; Hoffman et al., 2012).
Critically, the bead manufacturer SpheroTech provides cer-
tain classes of beads (e.g., RCP-30-5A) that have been cali-
brated to equivalent molecules of various standard fluorescent
stains (SpheroTech, 2001). These bead samples contain a mix-
ture of beads with multiple distinct levels of fluorescence and
non-uniform gaps between levels. This means that a linear con-
version from relative units to absolute units, such as Mole-
cules of Equivalent Fluorescein (MEFL) can be computed simply
by finding the peaks in the appropriate channel of a fluores-
cence histogram (e.g., the FITC channel for MEFL) and match-
ing against the list of calibration levels. Figure 7C shows such
an example of peak identification on a sample of SpheroTech
RCP-30-5A beads. Note the uneven gaps between peaks, which
allow unique identification even when only a few peaks are
visible.
Standard fluorophore measurements, however, do not pro-
vide comparable units between channels. Rather, each channel is
characterized with respect to a different fluorescent stain and the
relationship between fluorescent stains is in general different from
the relationship between the various fluorescent proteins. Further,
the fluorescence of various fluorescent proteins may depend on
the context in which they are expressed.
The TASBE method obtains equivalent units by selecting one of
the standard units (MEFL is recommended, as its greenish/yellow
range is one of the most widely used channels) and computing
a linear conversion factor from other channels via a multi-color
control. A multi-color control must strongly constitutively express
both the fluorescent protein measured in the standard channel and
at least one other fluorescent protein. Each fluorescent protein in
the multi-color control must be expressed using equivalent pro-
moters and context. In some contexts, such as mammalian cells,
this is relatively easy: there is little interaction between promoter
and coding sequence in an expression cassette, and each expres-
sion cassette can be placed in its own plasmid and cotransfected.
In bacterial cells, on the other hand, where the interaction with the
5′UTR is more significant and cotransfection typically is extremely
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FIGURE 7 | Larger versions of the sample controls shown with the
TASBE method workflow in Figure 6. (A) Computation of autofluorescence
from negative control. (B) Computation of spectral overlap from single
positive control. (C) Computation of from MEFL conversion factor from
calibration beads. (D) Computation of color conversion factor from multi-color
control.
difficult, it is first necessary to validate that there is sufficient insu-
lation between the fluorescent proteins by comparing different
constructs. Figure 7D shows an example of finding a linear con-
version factor from compensated Pacific Blue arbitrary units to
compensated FITC arbitrary units in mammalian HEK293 cells,
using a cotransfection of two plasmids, one expressing EBFP2, the
other EFYP, both under the same strong promoter. Multiplying by
the conversion factor changes Pacific Blue arbitrary units to FITC
arbitrary units, which can then be converted to MEFL and thus
allowing blue and yellow fluorescent proteins to be measured in
equivalent absolute units.
Finally, note that it is certainly possible to go beyond mea-
surements of equivalent fluorescence to estimates of number of
molecules. In many cases, this may be desirable to do (e.g., Rosen-
feld et al., 2007), but it is not always necessary and may intro-
duce additional noise. It is not always necessary because the base
requirement for effective modeling is absolute units, and MEFL
is already such. Further, fluorescence is being measured directly,
while molecule counts are inferred based on additional estimates;
differences in chemical environment, quenching, and other such
factors may affect the fluorescence per molecule, however, and can
create distortions in molecule estimates.
Putting it all together, these four stages of the TASBE method,
applied following the workflow in Figure 6, provide absolute unit
measurements from large numbers of single cells. This method
thereby provides an example of a measurement assay sufficient
to serve as a foundation for the development of model-driven
engineering methods, as will be shown in the next section.
5. FROMMEASUREMENT TO PREDICTION AND DEVICE
ENGINEERING
The results of calibrated large-scale per-cell measurement assays
can provide a firm foundation for the development of model-
driven engineering methods. This section demonstrates this rela-
tionship though presentation of three recent examples of ways
in which model-driven engineering methods have been derived
from calibrated flow cytometry data: improving the quality of data
obtained from assays through intra-sample validation, predicting
multi-component systems from models of individual components,
and debugging of complex novel components.
5.1. INTRA-SAMPLE VALIDATION
One of the frequent frustrations in biological experiments is the
difficulty in distinguishing between effects due to the intended
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subject of study versus those due to fluctuations and errors in
protocol or reagents. This difficulty can happen at any scale, from
individual samples to correlated sets of samples, to entire replicates
or experiments. Standard controls can help to identify problems,
but cannot detect problems that do not affect the control or affect
it more subtlely.
With the capability to measure and compare absolute fluores-
cent distributions across experiments, however, it is possible to
validate each individual sample using the distribution of fluores-
cence within the sample. This can be implemented, for any assay
not expected to have a strong impact on cell viability, by includ-
ing a strong constitutively expressed fluorescent protein in the test
construct. Often, this can even be done without modifying the
system under study at all, because such a fluorescent protein is
already included as a transfection marker.
Once a baseline model of variation for fluorescent distrib-
utions has been established (e.g., from single-positive controls
of the constitutive protein), then each sample can be validated
individually by evaluating its distribution of constitutive fluores-
cence. Whenever there is a significant difference from baseline,
it indicates either that something has varied significantly in the
protocol or that there is a strong impact on cell viability (e.g.,
resource competition, disabling of function in expression machin-
ery). Not only can this method detect problems with individual
samples but can also detect problems that may not be visible from
population-averaged data alone. For example, contamination or
sample degradation may not appear to have a significant effect on
the mean, but may contain anomalous “bumps” in other portions
of the distribution.
Figure 8 shows examples of applying this method to assays of
mammalian cells that have been cotransfected with both a circuit
under study and a constitutive transfection marker, showing the
expression histogram of the constitutive marker for each sample
in the experiment in a unique color. In each case, all of the sam-
ples in an experiment are compared on a single graph and fitted
against a bimodal log-normal distribution model of the expected
transfection distribution, where the upper component is success-
fully transfected cells and the lower component is untransfected
cells. For the experiments shown, the baseline model has been
established as the active component containing at least 50% of the
cells and having a geometric mean of approximately 107 MEFL.
Figure 8A shows an experiment with mostly normal transfec-
tions and a small number of anomalous samples: the three lowest
samples, whose distributions are clearly different than the rest,
are rejected while the rest are retained. Figure 8B shows a much
more extreme problem: an entire batch of data with a significantly
degraded transfection efficiency.
This approach thus constitutes a model-driven engineering
method, though not one directly tied to design. Rather, being able
to compare assays of per-cell sample data against an absolute dis-
tribution model enables both more principled sample rejection
and early detection of problems that might otherwise lead to large
amounts of wasted time and effort.
5.2. PREDICTION OF MULTI-COMPONENT SYSTEMS
Distribution models can also, of course, be applied directly to sys-
tem design, by using them to predict the consequences of different
design choices. By allowing examination of the different modes of
variation in the distribution of expression in a population of cells,
calibrated flow cytometry also allows more parameters relevant to
the mechanisms regulating expression to be quantified.
Consider, for example, the highly asymmetric expression distri-
bution shown in Figure 5B, from Beal et al. (2014). The asymme-
tries in the distribution correspond to separable effects of different
mechanisms regulating expression from Sindbis replicons trans-
fected into BHK-21 mammalian cells, as described in Section 1.
Combining such cotransfection data with time-series observations
of single replicon expression suffices to construct a model for the
expression over time of any dosage mixture of constitutive repli-
cons. This model, in turn, allows high-precision prediction and
engineering of the distribution of fluorescent expression, evolv-
ing over time, across a wide range of multi-replicon mixtures. An
example of such prediction is shown in Figure 9A, which com-
pares the predicted and experimentally observed distributions
of fluorescent expression from a mixture of 360 ng of mVenus
replicon (green), 360 ng of mKate replicon (red), and 1080 ng
FIGURE 8 | Population distribution of a constitutive fluorescent
protein (CFP) can be used to identify protocol problems, from
individual samples (A) to entire replicates (B). Data shown are from
sample material on Adler et al. (2014): solid lines are observed distribution,
dashed lines are bimodal model fit, used for quantitative comparison of
sample to expected distribution.
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FIGURE 9 | Component models built using calibrated flow
cytometry data enable high-precision predictions of
multi-component systems. For example, (A) models of single- and
dual-replicon transfection can predict (dashed lines) the observed
histogram for distribution of fluorescence (lines with stars, two
replicates) in a three-replicon mixture (figure from Beal et al. (2014),
and (B) repressor models can predict the observed mean and
population distribution of fluorescent expression of combinational
circuits such as the two-repressor cascade shown [figure from
Davidsohn et al. (2014)].
of EBFP2 replicon (blue), observed 50 h after transfection into
BHK-21 cells.
Another example is prediction of cotransfected circuits in
HEK293 mammalian cells from characterization of individual
repressors, as presented in Davidsohn et al. (2014). Here, cali-
brated flow cytometry was applied to produce a mixed mechanis-
tic/phenotypic model of the action of three-repressor/promoter
pairs (actually synthetic hybrid activator/repressor systems with
promoters activated by constitutive VP16Gal4 and repressed by
one of the transcriptional regulators TAL14, TAL21, or LmrA).
The distribution model is parametrized by time, by input expres-
sion as indicated by a co-expressed input fluorescent protein,
and by relative circuit dosage as indicated by a constitutive flu-
orescent protein. Models of individual repressors may then be
combined to create a model of a multi-repressor circuit, allow-
ing high-precision prediction of both the population mean and
the cell-to-cell variation of output protein expression for combi-
national circuits, as demonstrated in Davidsohn et al. (2014) for
multiple two-repressor cascades and three-repressor feed-forward
circuits, such as the TAL21–TAL14 cascade shown in Figure 9B.
From such predictions comes the ability to eliminate configu-
rations that are not productive to assay, and to prioritize assays
for those constructs mostly likely to prove successful, as dis-
cussed in Section 2, providing another example of model-driven
engineering based on calibrated flow cytometry.
5.3. IMPROVING DEVICE ENGINEERING
The deeper insight enabled by distribution models can also sup-
port model-driven engineering by helping to engineer devices
with less mutual constraint, which decreases the expected diffi-
culty of discovering acceptable system configurations as discussed
in Section 2. Here, the value of being able to compare population
distributions is that different aspects of the behavior of a regulatory
device can affect the structure of the distribution in different ways.
For example, when a constitutive fluorescent protein is included
in a high-variance cotransfection, it enables the behavior of the
device to be examined as a function of the relative number of
circuit copies. Since different aspects of a device’s behavior scale
differently with copy numbers, such sub-sample decomposition
can provide deeper insight into the causes of observed behavior.
For example, the degree of leakage in a repressor can be quantified
by the location of the inflection point where expression rises above
autofluorescence in a “minus” sample. Such forms of analysis, in
turn, allow the relative importance of different performance lim-
itations to be evaluated, enabling better focusing of engineering
efforts on the limiting factors in the design of a device.
For example, Kiani et al. (2014) presents new classes of repres-
sor devices based on the CRISPR system, which are characterized
using calibrated flow cytometry. Each device comprises a number
of different components, including constitutive expression of the
mutant protein Cas9m, which forms a targeted repressor when
it binds with gRNA expressed either directly or from introns,
Gal4VP16, which drives device expression unless overridden by
Cas9m, and a complex hybrid promoter including multiple target-
ing sites for both Cas9m and and Gal4VP16. In the early stages of
designing these new devices, there was a problem with high vari-
ability with respect to gRNA sequence: some gRNAs performed
very well, others inexplicably poorly. An assay with a constitutive
marker revealed that the less functional devices had a much lower
rate of leakage expression at the input stage, indicating that the
problem lay not in the action of the repressor complex on the
promoter, where it was originally believed the problem lay, but in
the expression of intronic gRNA. Refocusing engineering effort on
that aspect of the system led to new versions of devices with greatly
improved performance, which are the ones ultimately reported in
Kiani et al. (2014).
Thus, just as in the previous examples, absolute unit compari-
son of distributions of cell behaviors enables a more model-driven
approach to engineering biological organisms. The only difference
is that in this case, the set of interacting mechanisms that the meth-
ods are applied to is being conceived of by the engineers as a single
complex “device.”
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6. DISCUSSION AND DIRECTIONS FOR FUTURE
DEVELOPMENT
As the field of synthetic biology continues to expand, the problems
of measurement and design are becoming increasingly pressing.
This paper has developed an information-based measure that can
be used to determine the relative importance of good design meth-
ods in synthetic biology applications. Applying this measure shows
that precision modeling and design must play an important role in
future application development. Progress in modeling and design
has previously been inhibited by limitations in assay protocols that
made it difficult to effectively study the distribution of expression
levels within a cell population. Calibrated flow cytometry, how-
ever, is an example of a recently developed method that overcomes
this limitation, and applications of this method demonstrate how
comparison of expression level distributions can enable deeper
insight into cell behavior as well as high-precision modeling and
design.
6.1. DIRECTIONS FOR FUTURE DEVELOPMENT
The future of synthetic biology engineering rests on three com-
plementary pillars of development: high-throughput screening,
improved device families, and precision modeling and design.
The first two of these are already the subjects of heavy investiga-
tion and rapid progress, while the third has proved more elusive.
Recent results from calibrated flow cytometry, however, indicate
that there is now a sufficient foundation for renewed investigation
of precision modeling and design.
Strategic investment in this area has the potential for transfor-
mative impact across a broad space of applications for engineered
biological organisms. With respect to calibrated flow cytometry in
particular, there are three key directions for work:
• Exploitation and integration of calibrated flow cytometry: cal-
ibrated flow cytometry is a readily accessible technology, as it
builds on instruments and methods already widely in use, requir-
ing only a few simple additional controls. When combined with
more sophisticated data analysis, it has the potential to radically
improve the amount of insight and precision of models that can
be derived from experiments, as illustrated in Section 5. Signifi-
cant impact is thus likely to be obtained from the dissemination
and exploitation of calibrated flow cytometry techniques, and
their integration with a wide variety of systems and synthetic
biology projects.
• Application to a broader range of organisms: at present, cali-
brated flow cytometry has been applied primarily to the engi-
neering of sensing and control circuits in mammalian cells.
Preliminary work has already begun on extension to other cell
types, as discussed in Section 4, each of which may require its
own modifications and refinements in order to operate correctly:
for example, multi-color controls are harder to calibrate in bac-
teria, while plant cells have extremely strong autofluorescence
due to chlorophyll.
• Application beyond sensing and control circuits: calibrated flow
cytometry should also be applicable to problems outside of the
realm of sensing and control circuits, though it will likely need to
be used in combination with other assays. For example, it should
be possible to examine population distributions for chemical
synthesis with calibrated metabolite sensors, or to apply cali-
brated flow to tissue engineering by using it in combination
with imaging.
Calibrated flow cytometry, of course, is just one of many poten-
tial assays for obtaining information to enable high-precision
modeling and design. In fact, fluorescence is far from an ideal
quantity for such assays, as it is often only a proxy measure for
other, more relevant properties of cells. An important longer term
goal is thus to develop new assays that can provide the same power
to examine population distributions, but for other quantities such
as molecule count or the configuration of sub-cellular structures.
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